Ranitidine and Exforge drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ranitidine (ranitidine) and Exforge (amlodipine besylate; valsartan). Common drug interactions include gastritis among females and chest pain among males.

The phase IV clinical study analyzes what interactions people have when they take Ranitidine and Exforge. It is created by eHealthMe based on reports of 79 people who take the same drugs from the FDA, and is updated regularly.

What is Ranitidine?

Ranitidine has active ingredients of ranitidine. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 234,475 Ranitidine users. Check the latest studies of Ranitidine.

What is Exforge?

Exforge has active ingredients of amlodipine besylate; valsartan. It is often used in high blood pressure. eHealthMe is studying from 13,350 Exforge users. Check the latest studies of Exforge.

On Jul, 23, 2026

79 people who take Ranitidine and Exforge together, and have interactions are studied.

Ranitidine and Exforge drug interactions.

What are the common drug interactions of Ranitidine and Exforge, by gender? *:

female:

Gastritis (inflammation of stomach)
Pneumonia staphylococcal (pneumonia staphylococcal infections are usually caused by the organism staphylococcus aureus)
Pulmonary fibrosis (formation or development of excess fibrous connective tissue (fibrosis) in the lungs)
Road traffic accident
Vomiting
Anxiety
Brain mass
Fatigue (feeling of tiredness)
Hypoaesthesia (reduced sense of touch or sensation)
Memory impairment

male:

Chest pain
Infarction (obstruction of the blood supply to an organ or region of tissue)
Cardiac valve sclerosis (heart valve thickness)
Coronary artery occlusion (complete obstruction of blood flow in a coronary artery)
Coronary artery stenosis (narrowing of coronary artery)
Diastolic dysfunction
Eosinophil count increased
Fatigue (feeling of tiredness)
Functional residual capacity decreased
Haemoglobin decreased

What are the common drug interactions of Ranitidine and Exforge, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Chronic kidney disease
Decreased activity
Depression
Emotional distress
Impaired work ability
Pain
Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
Renal failure (kidney dysfunction)

40-49:

Ankle fracture
Chronic kidney disease
Fall
Fibula fracture
Haemarthrosis (haemarthrosis is where blood is able to enter the joint capsule)
Lower limb fracture
Nerve injury
Osteoporosis (bones weak and more likely to break)
Renal failure (kidney dysfunction)
Renal injury (kidney injury)

50-59:

Brain mass
Nephrogenic anaemia (anaemia due to kidney disease)
Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
Dyspnoea (difficult or laboured respiration)
Fall
Hypernatraemia (an abnormally high plasma concentration of sodium ions)
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Hypervolaemia (abnormally increased volume of blood)
Hypoaesthesia (reduced sense of touch or sensation)
Immune system disorder

60+:

Chest pain
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Blood sodium increased
Cardiac valve sclerosis (heart valve thickness)
Coronary artery occlusion (complete obstruction of blood flow in a coronary artery)
Coronary artery stenosis (narrowing of coronary artery)
Diastolic dysfunction
Eosinophil count increased
Functional residual capacity decreased
Haemoglobin decreased

What are the existing conditions these people have? *

High Blood Pressure: 39 people, 49.37%
High Blood Cholesterol: 20 people, 25.32%
Diabetes: 15 people, 18.99%
Pain: 14 people, 17.72%
Indigestion: 10 people, 12.66%
Asthma: 8 people, 10.13%
Depression: 8 people, 10.13%
Fluid Retention (an abnormal accumulation of fluid in the blood): 8 people, 10.13%
Osteoporosis (bones weak and more likely to break): 7 people, 8.86%
Cardiac Disorder: 7 people, 8.86%

* Approximation only. Some reports may have incomplete information.

Do you take Ranitidine and Exforge?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously